SCHEMBL4370565

SCHEMBL4370565

N#Cc1ccc(-c2nccnc2Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.44
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
CYP11B2 P19099 1/20 0.42
MMP3 P08254 1/20 0.41
SLC22A12 Q96S37 1/20 0.40
PDE10A Q9Y233 2/20 0.39
EGLN2 Q96KS0 1/20 0.38
CYP19A1 P11511 1/20 0.38
NOTUM Q6P988 1/20 0.38
KIF11 P52732 2/20 0.37
MAOB P27338 2/20 0.37
MAOA P21397 1/20 0.37
NSD2 O96028 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18448560 0.77 TDO2 (0.44) TDO2CCNB2CDK1CCNB1GSK3A
SCHEMBL4367442 0.77 TDO2 (0.44) TDO2CCNB2CDK1CCNB1GSK3A
SCHEMBL25428487 0.74 TDO2 (0.42) TDO2CYP11B2MMP3SLC22A12EGLN2
SCHEMBL31051290 0.74 PDE3B (0.41) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL22270629 0.73 APP (0.47) TDO2CCNB2CDK1CCNB1GSK3A
SCHEMBL8893483 0.73 ALOX15 (0.41) TDO2CDK5CDK5R1SLC22A12NOTUM
SCHEMBL25779260 0.72 SLC22A12 (0.49) TDO2CCNB2CDK1CCNB1GSK3A
SCHEMBL31337414 0.71 AR (0.49) SLC22A12NSD2
SCHEMBL18449675 0.70 MAPT (0.52) TDO2CYP19A1
SCHEMBL4152103 0.70 CYP2A6 (0.51) TDO2CYP11B2SLC22A12EGLN2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058076-A1 2-PYRAZINONE DERIVATIVES AND THEIR USE AS INHIBITORS OF NEUTROPHILE ELASTASE ASTRAZENECA AB (SE) 2009-05-07 WO disclosed